View in EDS

1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review.

Saved in:
Bibliographic Details
Title: 1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review.
Authors: Escalante Romero, L.1 (AUTHOR), Queiroz Costa Neto, I.2 (AUTHOR), Antunes, V.L.J.3 (AUTHOR), Matos Correia Rodrigues, M.1 (AUTHOR), Polo Mercado, J.R.4 (AUTHOR), Monteiro Caran, E.1 (AUTHOR)
Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS694-S695. 2p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179692484
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: 1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Escalante+Romero%2C+L%2E%22">Escalante Romero, L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Queiroz+Costa+Neto%2C+I%2E%22">Queiroz Costa Neto, I.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Antunes%2C+V%2EL%2EJ%2E%22">Antunes, V.L.J.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Matos+Correia+Rodrigues%2C+M%2E%22">Matos Correia Rodrigues, M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Polo+Mercado%2C+J%2ER%2E%22">Polo Mercado, J.R.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Monteiro+Caran%2C+E%2E%22">Monteiro Caran, E.</searchLink><relatesTo>1</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2024 Supplement 2, Vol. 35, pS694-S695. 2p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179692484
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.annonc.2024.08.1089
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 2
        StartPage: S694
    Titles:
      – TitleFull: 1030P Survival rates in high-risk neuroblastoma patients undergoing anti-GD2 immunotherapy: A single arm meta-analysis and systemic review.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Escalante Romero, L.
      – PersonEntity:
          Name:
            NameFull: Queiroz Costa Neto, I.
      – PersonEntity:
          Name:
            NameFull: Antunes, V.L.J.
      – PersonEntity:
          Name:
            NameFull: Matos Correia Rodrigues, M.
      – PersonEntity:
          Name:
            NameFull: Polo Mercado, J.R.
      – PersonEntity:
          Name:
            NameFull: Monteiro Caran, E.
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 09
              Text: 2024 Supplement 2
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 09237534
          Numbering:
            – Type: volume
              Value: 35
          Titles:
            – TitleFull: Annals of Oncology
              Type: main
ResultId 1